Literature DB >> 30127671

Synchronous bilateral breast cancer patients submitted to conservative treatment and brachytherapy - The experience of a service.

Joana Pinheiro1, Darlene Rodrigues1, Pedro Fernandes2, Alexandre Pereira3, Lurdes Trigo2.   

Abstract

INTRODUCTION: The incidence of breast carcinoma (BC) has increased in the last years. Between 2 and 12% of patients diagnosed with BC will develop bilateral breast carcinoma (BBC). The treatment of these carcinomas is more aggressive than unilateral BC.
PURPOSE: To perform a retrospective qualitative analysis of BBC patients whose treatment has included brachytherapy (BT) and to present a revised literature on this issue.
MATERIAL AND METHODS: The cases of BBC whose treatment included brachytherapy were revised. The literature on this issue was refreshed.
RESULTS: Five women, aged between 54 and 78 at the time of the diagnosis, submitted to conservative surgery followed by external radiotherapy (RT) with boost of BT or exclusive BT (APBI), in the IPO-P BT Service between 2003 and 2016. DISCUSSION: The patients with BBC have slightly higher rates of local recurrences, mostly in the tumor bed, where there is a higher risk of local recurrence. Patients treated with BT had lower rates of recurrences than those treated with photons and electrons.
CONCLUSIONS: BBC represents a complex challenge for doctors, because in some cases there is a tendency to use more aggressive treatments and, at the same time, it is not easy to achieve the timing for the correct treatment.

Entities:  

Keywords:  APBI; Bilateral breast carcinoma; Boost; Brachytherapy

Year:  2018        PMID: 30127671      PMCID: PMC6097463          DOI: 10.1016/j.rpor.2018.06.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  59 in total

1.  Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort.

Authors:  K R Beckmann; J Buckingham; P Craft; J E Dahlstrom; Y Zhang; D Roder; R Stuart-Harris
Journal:  Breast       Date:  2010-11-18       Impact factor: 4.380

2.  Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.

Authors:  Saskia Litière; Gustavo Werutsky; Ian S Fentiman; Emiel Rutgers; Marie-Rose Christiaens; Erik Van Limbergen; Margreet H A Baaijens; Jan Bogaerts; Harry Bartelink
Journal:  Lancet Oncol       Date:  2012-02-27       Impact factor: 41.316

Review 3.  Epidemiology of contralateral breast cancer.

Authors:  Y Chen; W Thompson; R Semenciw; Y Mao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-10       Impact factor: 4.254

4.  Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure.

Authors:  I A Olivotto; M A Rose; R T Osteen; S Love; B Cady; B Silver; A Recht; J R Harris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-10       Impact factor: 7.038

5.  A case-control study of unilateral and bilateral breast carcinoma patients.

Authors:  L A Newman; A A Sahin; J E Cunningham; M L Bondy; N Q Mirza; G S Vlastos; G J Whitman; H Brown; T A Buchholz; M H Lee; S E Singletary
Journal:  Cancer       Date:  2001-05-15       Impact factor: 6.860

6.  Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost.

Authors:  Christine E Hill-Kayser; David Chacko; Wei-Ting Hwang; Neha Vapiwala; Lawrence J Solin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-24       Impact factor: 7.038

7.  Factors influencing survival in bilateral breast cancer.

Authors:  A S Al-Jurf; P R Jochimsen; L F Urdaneta; D H Scott
Journal:  J Surg Oncol       Date:  1981       Impact factor: 3.454

8.  The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.

Authors:  Philip Poortmans; Harry Bartelink; Jean-Claude Horiot; Henk Struikmans; Walter Van den Bogaert; Alain Fourquet; Jos Jager; Willem Hoogenraad; Patrick Rodrigus; Carla Wárlám-Rodenhuis; Laurence Collette; Marianne Pierart
Journal:  Radiother Oncol       Date:  2004-07       Impact factor: 6.280

9.  Bilateral primary breast cancer: a prospective study of disease incidence.

Authors:  M A Chaudary; R R Millis; E O Hoskins; M Halder; R D Bulbrook; J Cuzick; J L Hayward
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

10.  Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems.

Authors:  T Ohtake; R Abe; I Kimijima; T Fukushima; A Tsuchiya; K Hoshi; H Wakasa
Journal:  Cancer       Date:  1995-07-01       Impact factor: 6.860

View more
  1 in total

1.  The hidden breast lesions: A case report of bilateral breast cancer.

Authors:  Chaochao Dai; Lingyun Bao; Yanjuan Tan; Chenxiang Jiang
Journal:  J Clin Ultrasound       Date:  2021-12-25       Impact factor: 0.869

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.